Free Trial

Earnest Partners LLC Has $134.75 Million Stock Holdings in Integer Holdings Corporation $ITGR

Integer logo with Medical background

Key Points

  • Earnest Partners LLC reduced its stake in Integer Holdings Corporation (ITGR) by 1.9%, now holding approximately 3.27% of the company valued at $134.75 million.
  • Integer recently reported quarterly earnings of $1.55 per share, missing estimates slightly, while its revenue increased by 11.4% compared to last year.
  • Several analysts have recently modified their ratings and price targets for Integer, with an average consensus rating of "Buy" and a consensus price target of $140.25.
  • Want stock alerts on Integer? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Earnest Partners LLC trimmed its holdings in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 1.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,141,812 shares of the medical equipment provider's stock after selling 21,569 shares during the period. Earnest Partners LLC owned 3.27% of Integer worth $134,745,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in ITGR. Vaughan Nelson Investment Management L.P. acquired a new stake in Integer during the 1st quarter worth approximately $33,337,000. Nuveen LLC bought a new position in Integer during the 1st quarter worth $17,634,000. GAMMA Investing LLC increased its stake in Integer by 8,697.6% during the 1st quarter. GAMMA Investing LLC now owns 78,123 shares of the medical equipment provider's stock worth $92,190,000 after acquiring an additional 77,235 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Integer during the 4th quarter worth $7,889,000. Finally, Northern Trust Corp increased its stake in shares of Integer by 14.2% in the 4th quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider's stock valued at $55,974,000 after purchasing an additional 52,556 shares during the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on ITGR shares. Wall Street Zen upgraded Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. Raymond James Financial decreased their price target on Integer from $150.00 to $143.00 and set an "outperform" rating on the stock in a research note on Friday, July 25th. Truist Financial decreased their price target on Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a research note on Friday, July 25th. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and lifted their price target for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Finally, Wells Fargo & Company decreased their price target on Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a research note on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Buy" and a consensus price target of $140.25.

View Our Latest Stock Analysis on ITGR

Insider Activity

In other Integer news, Director Martin C. Maxwell sold 8,720 shares of Integer stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the transaction, the director directly owned 22,170 shares of the company's stock, valued at approximately $2,672,815.20. The trade was a 28.23% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Donald J. Spence sold 14,739 shares of Integer stock in a transaction dated Wednesday, June 4th. The stock was sold at an average price of $120.38, for a total value of $1,774,280.82. Following the transaction, the director directly owned 18,781 shares in the company, valued at $2,260,856.78. The trade was a 43.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.16% of the stock is currently owned by insiders.

Integer Trading Down 0.1%

NYSE ITGR opened at $108.66 on Wednesday. The company has a quick ratio of 2.18, a current ratio of 3.41 and a debt-to-equity ratio of 0.72. Integer Holdings Corporation has a twelve month low of $104.93 and a twelve month high of $146.36. The company has a market cap of $3.81 billion, a price-to-earnings ratio of 47.87, a price-to-earnings-growth ratio of 0.86 and a beta of 1.02. The business's fifty day moving average is $113.36 and its 200 day moving average is $118.60.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.02). Integer had a net margin of 4.61% and a return on equity of 12.27%. The firm had revenue of $476.00 million for the quarter, compared to analyst estimates of $464.37 million. During the same period last year, the business earned $1.30 EPS. The company's revenue was up 11.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. As a group, sell-side analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

About Integer

(Free Report)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Featured Articles

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR - Free Report).

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Integer Right Now?

Before you consider Integer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.

While Integer currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines